Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04577703
Status:
COMPLETED
Last Update Posted:
2020-10-08
First Post:
2020-09-16
Brief Title:
First-In-Human Phase I Trial of Ningetinib CT053PTSA in the Patients With Advanced Solid Tumors
Sponsor:
Sunshine Lake Pharma Co Ltd
Organization:
Sunshine Lake Pharma Co Ltd
Organization Data
Organization:
Sunshine Lake Pharma Co Ltd
Class:
INDUSTRY
Study ID:
PCD-DCT053-12-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sunshine Lake Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None